Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/23/3/547/612009/mdr382.pdf
Reference60 articles.
1. SFAltekruseCLKossaryMKrapchoSEER Cancer Statistics Review, 1975–2007Bethesda, MDNational Cancer Institutehttp://seer.cancer.gov/csr/1975_2007/(10 March 2011) based on November 2009 SEER data submission, posted to the SEER web site, 2010
2. Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?;Cardoso;Ann Oncol,2002
3. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer;Gradishar;J Clin Oncol,2005
4. Significantly Longer Progression-Free Survival With nab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer;Gradishar;J Clin Oncol,2009
5. Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions;Lin;Invest New Drugs,2007
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Implementation of antibody-drug conjugates in HER2-positive solid cancers: Recent advances and future directions;Biomedicine & Pharmacotherapy;2024-05
2. Semisynthetic phytochemicals in cancer treatment: a medicinal chemistry perspective;RSC Medicinal Chemistry;2024
3. α-Hederin Saponin Augments the Chemopreventive Effect of Cisplatin against Ehrlich Tumors and Bioinformatic Approach Identifying the Role of SDF1/CXCR4/p-AKT-1/NFκB Signaling;Pharmaceuticals;2023-03-07
4. Radiotherapy in Breast Cancer;Interdisciplinary Cancer Research;2023
5. Mechanistic insights expatiating the biological role and regulatory implications of estrogen and HER2 in breast cancer metastasis;Biochimica et Biophysica Acta (BBA) - General Subjects;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3